Orthofix International | OFIX - Cash And Equivalent


Orthofix International reported $86.32M in Cash and Equivalent for its fiscal quarter ending in September of 2026.





Cash And Equivalent Change Date
Accuray USD 41.29M 22.05M Dec/2025
AngioDynamics USD 41.64M 14.26M Sep/2025
Artivion USD 48.4M 28.92M Sep/2026
AtriCure USD 187.03M 19.24M Sep/2026
Dexcom USD 961.4M 143.6M Sep/2026
EDAP TMS EUR 15.01M 14.82M Mar/2026
Globus Medical USD 441.27M 66.47M Sep/2026
Inogen USD 106.48M 2.79M Sep/2025
Insulet USD 584.4M 49.5M Sep/2026
Integra LifeSciences USD 252.26M 37.85M Sep/2026
J&J USD 16.91B 3.51B Sep/2026
Medtronic USD 1.69B 258M Jun/2026
Mesa Laboratories USD 28.98M 8.55M Dec/2025
Orthofix International USD 86.32M 17.49M Sep/2026
Plus Therapeutics USD 2.37M 656K Jun/2026
STAAR Surgical USD 133.61M 14.97M Sep/2026
Stryker USD 3.27B 120M Sep/2026
Tandem Diabetes Care USD 72.84M 10.02M Sep/2026
Teleflex USD 430.46M 130.31M Sep/2026
Veracyte USD 199.83M 99.69M Sep/2026
Zimmer Biomet Holdings USD 399.9M 10.1M Sep/2026